A detailed history of Jump Financial, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Jump Financial, LLC holds 161,608 shares of MYGN stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
161,608
Previous 10,591 1425.9%
Holding current value
$1.08 Million
Previous $56,000 1985.71%
% of portfolio
0.01%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$3.84 - $7.84 $579,905 - $1.18 Million
151,017 Added 1425.9%
161,608 $1.17 Million
Q2 2025

Aug 13, 2025

SELL
$3.84 - $8.84 $475,180 - $1.09 Million
-123,745 Reduced 92.12%
10,591 $56,000
Q1 2025

May 14, 2025

BUY
$8.87 - $14.98 $1.19 Million - $2.01 Million
134,336 New
134,336 $1.19 Million
Q3 2024

Nov 14, 2024

BUY
$23.97 - $28.6 $787,582 - $939,710
32,857 New
32,857 $899,000
Q4 2023

Oct 21, 2024

SELL
$13.91 - $21.32 $916,349 - $1.4 Million
-65,877 Reduced 77.57%
19,047 $364,000
Q4 2023

Feb 07, 2024

SELL
$13.91 - $21.32 $916,349 - $1.4 Million
-65,877 Reduced 77.57%
19,047 $364,000
Q3 2023

Oct 21, 2024

BUY
$15.99 - $23.22 $187,178 - $271,813
11,706 Added 15.99%
84,924 $1.36 Million
Q3 2023

Nov 07, 2023

BUY
$15.99 - $23.22 $187,178 - $271,813
11,706 Added 15.99%
84,924 $1.36 Million
Q2 2023

Oct 21, 2024

BUY
$17.56 - $23.76 $1.29 Million - $1.74 Million
73,218 New
73,218 $1.7 Million
Q2 2023

Aug 07, 2023

BUY
$17.56 - $23.76 $1.29 Million - $1.74 Million
73,218 New
73,218 $1.7 Million
Q4 2022

Feb 13, 2023

BUY
$14.51 - $20.99 $667,880 - $966,148
46,029 New
46,029 $667,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $541M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.